Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POINT: Magnesium for Neuroprotection in CABG
NCT00041392Phase 2Completed
- Sponsor
- Duke University
- Start
- Dec 2001
- Primary completion
- May 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium in Post-operative cognitive dysfunction (POCD), sponsored by Duke University. Started Dec 2001; status: completed.
02
Drugs
magnesium
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT00041392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041392.